TOTH A ERNEST JR
Chief Financial Officer
TOTH A ERNEST JR has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 7, 2026.
On the most recent filing, TOTH A ERNEST JR is listed as Chief Financial Officer at Aquestive Therapeutics, Inc. Inside the rolling window, TOTH A ERNEST JR reported no open-market purchases and 1 open-market sale totaling $243K in AQST.
Companies traded
Other insiders at AQST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$243K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has TOTH A ERNEST JR made?
TOTH A ERNEST JR has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does TOTH A ERNEST JR trade?
TOTH A ERNEST JR has filed SEC Form 4 disclosures for 1 company, including AQST.
When was TOTH A ERNEST JR's most recent SEC Form 4 filing?
TOTH A ERNEST JR's most recent SEC Form 4 filing on Tracefour is dated May 7, 2026.
What is TOTH A ERNEST JR's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, TOTH A ERNEST JR is listed as Chief Financial Officer.
What is TOTH A ERNEST JR's total buy and sell value in the current window?
Inside the rolling retention window, TOTH A ERNEST JR bought $0 and sold $243K based on SEC Form 4 filings.
What was TOTH A ERNEST JR's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 58,254 AQST shares on 2026-03-10, worth $243K, per SEC Form 4 filings.